In the latest multicenter retrospective study conducted on 604 acromegaly patients, the authors suggested that cosecreting tumors should be considered when the tumors stained positive for GH and PRL with elevated PRL levels or serum PRL levels above 100 ng/dL, regardless of the IHC result of PRL (34). This evidence concerns the gene GH1 and acromegaly.